Uncategorized

One in 4 Americans (24%) will develop heart failure in their lifetime, according to a new report published Sept. 24 in the Journal of Cardiac Failure.

Along with the premarket approval of Siemens' 3D breast-imaging technology, the FDA  approved seven oncology and hematology drugs in September. 

Six U.S. health systems and cancer centers have joined the recently launched Together for Supportive Cancer Care consortium alongside more than 30 research institutions and advocacy groups with the aim to make supportive cancer care the standard of care.

Michel Sadelain, MD, PhD, a CAR-T therapy innovator and one of the world's top immunologists, has left New York City-based Memorial Sloan Kettering Cancer Center for two new roles at Columbia University Irving Medical Center, also in New York City.

Florida has the most top-ranked hospitals for angioplasty in the U.S., according to the WebMD Choice Awards.

From 2012 to 2021, breast cancer incidence has risen 1%, with steep increases among young women and Asian American/Pacific Islander women, according to the American Cancer Society. 

Two Michigan hospitals had the highest excess readmission ratios for heart attack patients in the U.S. between July 1, 2019, and June 30, 2022, according to CMS data released July 31.

Moffitt Cancer Center patients will soon have access to on-demand virtual care services. 

An AI-empowered blood test was able to more reliably identify ovarian cancer by detecting DNA fragments and protein biomarkers, according to a study published Sept. 30 in the American Association for Cancer Research's journal, Cancer Discovery.

The FDA's Oncologic Drugs Advisory Committee has voted to restrict the use of nivolumab and pembrolizumab immunotherapy drugs based on the programmed death-ligand 1 expression levels of patients, according to a Sept. 30 Medscape report.